Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2026-525871-24-00Phase 2Authorised
Phase 2, randomised, open-label trial of oxygen in fracture-related infection (FRI) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Number of subjects included after one year study duration, Number of hyperbaric oxygen therapy (HBOT) sessions completed per subject and 1 more. Planned start Jun 2026; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2026-525871-24-00.